Dr. Öğr. Üyesi SİMLA OLĞAÇ

Yayın Ağı

Makaleler 3

1. Identification of novel antiplatelet agents by targeting Glycoprotein VI: A combined virtual screening study

OLĞAÇ S., OLĞAÇ A., YENİCESU İ., ÖZKAN Y.

BIOORGANIC CHEMISTRY , cilt.121, 2022 (SCI-Expanded, Scopus)

2. Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives

YURTTAŞ L., Abu Mohsen U., ÖZKAN Y., Cobanoglu S., LEVENT S., KAPLANCIKLI Z. A.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.31, sa.6, ss.1177-1183, 2016 (SCI-Expanded)

3. Synthesis of some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives incorporating aminothiazole moiety and investigation of their antioxidant, acetylcholinesterase, and butyrylcholinesterase inhibitory activities

Yamali C., Gulcan H. O., Kahya B., Cobanoglu S., Şüküroğlu M. K., Doğruer D. S.

MEDICINAL CHEMISTRY RESEARCH , cilt.24, sa.3, ss.1210-1217, 2015 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. INVESTIGATION OF THE MECHANISM OF PLATELET INHIBITOR CANDIDATES WITH ANTIPLATELET EFFECTS

Olğaç S., Özkan Y., Göral Ş.

14th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 25 - 28 Haziran 2024, ss.143, (Özet Bildiri)

2. Virtual Screening to Discover Drug Candidates Targeting Platelet Receptors

OLĞAÇ S., OLĞAÇ A., YENİCESU İ., ÖZKAN Y.

Asian Federation of Medicinal Chemistry (AFMC) 12th International Symposium, İstanbul, Türkiye, 8 - 11 Eylül 2019, (Özet Bildiri)

3. Antiplatelet aggregation of the secondary metabolites isolated from the aerial parts of Chrysophthalmum montanum (DC.) Boiss.

AYAZ F., ÖZKAN Y., OLĞAÇ S., GÖREN N., ÇALIŞ İ., Choudhary M. I., et al.

2nd International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2019), 28 - 29 Haziran 2019, (Özet Bildiri)

4. Virtual Screening for Small Molecule Inhibitors of Glycoprotein VI (GPVI)

OLĞAÇ S., OLĞAÇ A., ÖZKAN Y.

4th European Platelet Network (EUPLAN), 19 - 21 Eylül 2018, (Özet Bildiri)

5. In Vitro Antiplatelet Studies on Virtually Discovered GPVI Drug Candidates

OLĞAÇ S., Olgaç A., ÖZKAN Y.

12th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 Haziran 2018, (Özet Bildiri)

6. ANTIPLATELET ACTIVITY OF ISOLATED FLAVONOLS FROM SALSOLA GRANDIS AERIAL PARTS

KÜÇÜKBOYACI N., ÇALIŞ İ., ÖZKAN Y., OLĞAÇ S.

ISOPS 12th, 26 - 29 Haziran 2018, (Özet Bildiri)

7. ANTIPLATELET ACTIVITY OF LIGNANS FROM TAXUS BACCATA

KÜÇÜKBOYACI N., ÖZKAN Y., OLĞAÇ S., ŞENER B.

ISOPS 12, 26 - 29 Haziran 2018, (Özet Bildiri)

8. Investigation of Novel Platelet Receptor GPVI Inhibitor Candidates

OLĞAÇ S., OLĞAÇ A., ÖZKAN Y.

2nd International Gazi Pharma Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

9. Structure Based Virtual Screening to Discover Platelet GPVI Inhibitors

OLĞAÇ S., OLĞAÇ A., ÖZKAN Y.

Third European Platelet Network (EUPLAN) Conference 2016, Bad Homburg vor der Höhe, Almanya, 21 - 23 Eylül 2016, (Özet Bildiri)

10. Screening FDA Approved Drugs to Discover Potent GPVI Inhibitors

OLĞAÇ S., OLĞAÇ A., ÖZKAN Y.

XXIV National Meeting in Medicinal Chemistry, Perugia, İtalya, 11 - 14 Eylül 2016, (Özet Bildiri)

11. Evias Web Services Cloud Based Drug Discovery Platform

OLĞAÇ A., BUDAK G., OLĞAÇ S., NUTI R., CAROTTI A., BANOĞLU E.

21st European Symposium on Quantitative Structure-Activity Relationship, Verona, İtalya, 4 - 08 Eylül 2016, (Özet Bildiri)

12. Evias Cloud Based Drug Discovery Platform

OLĞAÇ A., BUDAK G., OLĞAÇ S., NUTI R., CAROTTI A., BANOĞLU E.

High-Performance Modelling and Simulation for Big Data Applications - Management Committee & Working Group Meeting, Dublin, İrlanda, 25 - 26 Nisan 2016, (Özet Bildiri)

13. Synthesis of Some 3(2H)-Pyridazinone and 1(2H)-Phthalazinone Derivatives Incorporating Aminothiazole Moiety and Investigation of Their Antioxidant, Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activities.

DOĞRUER D. S., YAMALI C., KILIÇ B., OLĞAÇ S., ŞÜKÜROĞLU M. K.

XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC2014), Lizbon, Portekiz, 7 - 11 Eylül 2014, (Özet Bildiri)

14. Koroner Aterosklerozda Homosistein Tiyolaktonaz ve LDL Oksidasyonu

Altınay A., Tulmaç M., OLĞAÇ S., KISA Ü., Şimşek B., ÖZKAN Y.

XXV. Ulusal Biyokimya Kongresi, Türkiye, 3 - 06 Eylül 2013, (Özet Bildiri)

Kitaplar 1

1. Cloud-Based High Throughput Virtual Screening in Novel Drug Discovery

Olğaç A., Türe A., Olğaç S., Möller S.

High-Performance Modelling and Simulation for Big Data Applications, Kolodziej Joanna,Gonzalez-Velez Horacio, Editör, Springer, Zug, ss.250-278, 2019

Metrikler

Dr. Öğr. Üyesi SİMLA OLĞAÇ

Yayınlar & Eserler

1. Identification of novel antiplatelet agents by targeting Glycoprotein VI: A combined virtual screening study

2. Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives

3. Synthesis of some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives incorporating aminothiazole moiety and investigation of their antioxidant, acetylcholinesterase, and butyrylcholinesterase inhibitory activities

1. INVESTIGATION OF THE MECHANISM OF PLATELET INHIBITOR CANDIDATES WITH ANTIPLATELET EFFECTS

2. Virtual Screening to Discover Drug Candidates Targeting Platelet Receptors

3. Antiplatelet aggregation of the secondary metabolites isolated from the aerial parts of Chrysophthalmum montanum (DC.) Boiss.

4. Virtual Screening for Small Molecule Inhibitors of Glycoprotein VI (GPVI)

5. In Vitro Antiplatelet Studies on Virtually Discovered GPVI Drug Candidates

6. ANTIPLATELET ACTIVITY OF ISOLATED FLAVONOLS FROM SALSOLA GRANDIS AERIAL PARTS

7. ANTIPLATELET ACTIVITY OF LIGNANS FROM TAXUS BACCATA

8. Investigation of Novel Platelet Receptor GPVI Inhibitor Candidates

9. Structure Based Virtual Screening to Discover Platelet GPVI Inhibitors

10. Screening FDA Approved Drugs to Discover Potent GPVI Inhibitors

11. Evias Web Services Cloud Based Drug Discovery Platform

12. Evias Cloud Based Drug Discovery Platform

13. Synthesis of Some 3(2H)-Pyridazinone and 1(2H)-Phthalazinone Derivatives Incorporating Aminothiazole Moiety and Investigation of Their Antioxidant, Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activities.

14. Koroner Aterosklerozda Homosistein Tiyolaktonaz ve LDL Oksidasyonu

1. Cloud-Based High Throughput Virtual Screening in Novel Drug Discovery

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim